Paris, France, June 15 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent Private Equity firm dedicated to biotech and biopharma, today announces that it has become a key investor as part of a $67 million Series B financing round in Alentis Therapeutics (Alentis). The Swiss biotech company, a spin-off of French Inserm with R&D in [...]
BASEL, Switzerland and SAN DIEGO, Calif., June 10 (Korea Bizwire) — Bright Peak Therapeutics, a biotechnology company developing next-generation cytokine immunotherapies to treat cancer and autoimmune disease, today announced that it raised $107 million in a Series B financing. The round was led by RA Capital, with participation by founding investor Versant Ventures and new [...]
SANTA CLARA, Calif., March 4 (Korea Bizwire) – Webscale, the Safest Cloud for Ecommerce, today announced the closing of $26 million in growth capital financing from investors and Silicon Valley Bank. The Series C round was led by BGV, STCAP Ventures and Mohr Davidow Ventures, with participation from Grotech Ventures. This investment in Webscale’s comprehensive ecommerce platform is more pertinent than ever. [...]
Nice, France, Dec. 14 (Korea Bizwire) – InnoSkel, a newly launched platform biotechnology company pioneering gene therapies for rare skeletal diseases, today announced that it has raised €20 million in a Series A financing round. The fundraise was co-led by Jeito Capital and Vida Ventures, with additional support from Turenne Group and Région Sud Investissement. Proceeds [...]
DURHAM, N.C., Nov. 10 (Korea Bizwire) — CoImmune, Inc., an immuno-oncology company developing cell-based therapeutics to treat unmet medical needs in blood-borne and solid tumor indications, today announced the closing of a $45M Series A financing. CoImmune will use the proceeds from the financing to fund its ongoing Phase 2b trial for lead asset, CMN-001, [...]
Paris, France, Sept. 14 (Korea Bizwire) – Jeito Capital (“Jeito”), a rapidly emerging independent investor dedicated to biotech and biopharma, today announced that it has co-led a $110 million Series A financing in Neogene Therapeutics, Inc. (“Neogene”), a pre-clinical stage biotechnology company pioneering a new class of fully personalized neo-antigen T cell therapies to treat cancer. [...]
VANCOUVER, British Columbia, July 22 (Korea Bizwire) — General Fusion announced today that it has closed additional financing in support of its Fusion Demonstration Plant (FDP) program. Highlighting this new financing are two more globally recognized institutional investors, led by GIC, together with the deep technology fund IBX, in a significant expansion of institutional support [...]
AUCKLAND, New Zealand, Jan. 9 (Korea Bizwire) — Soul Machines, the ground-breaking company re-imagining how humans connect with machines, today announced its US$40 million series B financing. Soul Machines is an AGI Research company developing the world’s leading Autonomous Animation platform to help humanize brands and the ways people engage with them. The investment was [...]
DANBURY, Conn., Dec. 20 (Korea Bizwire) – Today, FuelCell Energy, Inc. (Nasdaq: FCEL), a global leader in delivering clean, innovative and affordable molten-carbonate fuel cell solutions, outlined the significant construction progress it has made to-date, the expected delivery schedule and the current financing approach for the CMEEC Fuel Cell Micro-Grid Project on the U.S. Naval Submarine Base in [...]
VANCOUVER, British Columbia, Dec. 16 (Korea Bizwire) — General Fusion announced that it has successfully closed USD$65 million of Series E equity financing. The financing was led by Temasek, a global investment company headquartered in Singapore. This USD$65 million of new financing, together with the release of CAD$50 million in additional investment from Canada’s Strategic [...]